We are live on
!
Find out more
CCC
Chelsea Counsel Company Portfolio holdings
AUM
$225M
1-Year Est. Return
45.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.39%
1 Year Est. Return
+45.99%
3 Year Est. Return
+94.6%
5 Year Est. Return
+122.61%
10 Year Est. Return
+380.48%
AUM
$512M
AUM Growth
+$19.9M
(+4%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
34.55%
Holding
137
New
12
Increased
33
Reduced
43
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Plains All American Pipeline
PAA
|
+$1.65M |
| 2 |
ABB
ABB Ltd
ABB
|
+$974K |
| 3 |
Qualcomm
QCOM
|
+$808K |
| 4 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$655K |
| 5 |
VRN
Veren
VRN
|
+$653K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
+$7.75M |
| 2 |
CBI
Chicago Bridge & Iron Nv
CBI
|
+$5M |
| 3 |
Duke Energy
DUK
|
+$2.42M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$1.52M |
| 5 |
Apple
AAPL
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 21.63% |
| 2 | Industrials | 20.16% |
| 3 | Healthcare | 10.09% |
| 4 | Communication Services | 9.51% |
| 5 | Consumer Staples | 9.04% |
Similar funds
BAM
NIA
BMC
PHM
EAM
SFC
TWA
CP
Chelsea Counsel Company's Q2 2014 Portfolio in Review
As of Q2 2014, Chelsea Counsel Company held 137 positions worth $512M, up 4% from $492M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Chelsea Counsel Company's Q2 2014 filing shows 12 new, 33 increased, 43 reduced and 8 closed positions. Its largest new stake was Biogen: 1,623 shares worth $512K. The largest sale was Unilever NV New York Registry Shares, an estimated $7.75M.
By sector, the portfolio is most concentrated in Energy at 22% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.
- Chelsea Counsel Company's largest Q2 2014 buy was Biogen: 1,623 shares worth $512K.
- Chelsea Counsel Company added most to Plains All American Pipeline in Q2 2014, an estimated $1.65M increase.
- Chelsea Counsel Company's biggest Q2 2014 reduction was Unilever NV New York Registry Shares, cutting an estimated $7.75M.
- Chelsea Counsel Company fully exited Celgene Corp in Q2 2014, selling an estimated $670K.
- Chelsea Counsel Company's ten largest holdings make up 35% of its $512M portfolio in Q2 2014.
- Chelsea Counsel Company opened 12 new positions and closed 8 in Q2 2014.
- Chelsea Counsel Company's portfolio value rose 4% quarter-over-quarter to $512M.
Based on Chelsea Counsel Company's 13F filing for Q2 2014, filed 4 Sep 2014.